Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism
| Image |  |
|---|---|
| Description | scientific article published on 17 November 2020 |
| Author/s |
author: Maureen Murphy Samantha S Soldan |
| Publication date | November 17, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |